MOLCURE
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $7.2M
Investors
- 6
About MOLCURE
MOLCURE Inc.Founded in 2013 and headquartered in Kanagawa, Japan, MOLCURE Inc. specializes in AI-driven molecular design. The CEO and founder, Ryu Ogawa, has a history of leadership in molecular design and innovation.MOLCURE Inc. specializes in AI-driven molecular design, providing a suite of advanced technologies aimed at accelerating the drug discovery process. Their core offerings include an AI-powered de novo discovery platform, high-throughput screening capabilities, next-generation sequencing (NGS), and an AI-based lead optimization platform. These products are designed for pharmaceutical and biotechnology companies seeking to streamline their drug development efforts by discovering novel molecules, optimizing candidate molecules, and conducting comprehensive analyses of biological data.MOLCURE Inc. generates revenue through strategic partnerships and collaborations with pharmaceutical companies, providing services on a project basis or through ongoing consulting agreements. Their business model focuses on B2B transactions, delivering tailored solutions that may include subscriptions to their proprietary AI platforms and specialized project services. Revenue is derived from the deployment of their flagship products, such as the AI antibody discovery platform, which assists in molecular design and optimization. They aim to enhance their business development efforts to improve quality of life (QOL) through innovative solutions. Specific markets targeted for growth include North America and Europe, with initiatives expected to roll out within the next two years.
Who invested in MOLCURE
6 investors across 1 round
See all investors in MOLCURE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Aug 18, 2021
Amount
$7.2M
Investors
Questions about MOLCURE
Who invested in MOLCURE?
MOLCURE has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MOLCURE raised?
MOLCURE has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MOLCURE last raise money?
MOLCURE's most recent round on record is a Series C, in Aug 2021.
What does MOLCURE do?
MOLCURE is a biotechnology company.
Where is MOLCURE headquartered?
MOLCURE is headquartered in Kanagawa, Japan.
Which VCs invest in companies like MOLCURE?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MOLCURE's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like MOLCURE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.